ASO Visual Abstract: Serum CEA as prognostic marker for overall survival in patients with localized pancreatic adenocarcinoma and nonelevated ca19-9 levels treated with FOLFIRINOX as initial treatment - A TAPS Consortium study Miscellaneous
| Authors: | Doppenberg, D.; Stoop, T. F.; van Dieren, S.; Katz, M. H. G.; Janssen, Q. P.; Nasar, N.; Prakash, L. R.; Theijse, R. T.; Tzeng, C. W. D.; Wei, A. C.; Zureikat, A. H.; Groot Koerkamp, B.; Besselink, M. G.; and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium |
| Title: | ASO Visual Abstract: Serum CEA as prognostic marker for overall survival in patients with localized pancreatic adenocarcinoma and nonelevated ca19-9 levels treated with FOLFIRINOX as initial treatment - A TAPS Consortium study |
| Keywords: | retrospective studies; fluorouracil; pancreatic neoplasms; antineoplastic agent; adenocarcinoma; antineoplastic combined chemotherapy protocols; ca 19-9 antigen; carcinoembryonic antigen; pathology; retrospective study; tumor marker; irinotecan; folinic acid; pancreas tumor; oxaliplatin; leucovorin; ca-19-9 antigen; humans; prognosis; human; folfirinox; biomarkers, tumor |
| Journal Title: | Annals of Surgical Oncology |
| Volume: | 31 |
| Issue: | 3 |
| ISSN: | 1068-9265 |
| Publisher: | Springer |
| Date Published: | 2024-03-01 |
| Start Page: | 1954 |
| End Page: | 1955 |
| Language: | English |
| DOI: | 10.1245/s10434-023-14752-1 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
